Compare · BTI vs OBIO
BTI vs OBIO
Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Orchestra BioMed Holdings Inc. (OBIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTI and OBIO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- BTI is the larger of the two at $120.47B, about 397.7x OBIO ($302.9M).
- Over the past year, BTI is up 2.5% and OBIO is up 83.8% - OBIO leads by 81.3 points.
- OBIO has been more active in the news (10 items in the past 4 weeks vs 6 for BTI).
- BTI has more recent analyst coverage (15 ratings vs 9 for OBIO).
PerformanceBTI+2.52%OBIO+83.79%
2025-09-02+0.00%2026-09-01
- Company
- British American Tobacco Industries p.l.c.
- Orchestra BioMed Holdings Inc.
- Price
- $56.66+1.92%
- $5.04-0.10%
- Market cap
- $120.47B
- $302.9M
- 1M return
- -4.90%
- +22.45%
- 1Y return
- +2.52%
- +83.79%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- 2020
- News (4w)
- 6
- 10
- Recent ratings
- 15
- 9
BTI
British American Tobacco Industries p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Latest BTI
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Charlotte's Web Reports Second Quarter 2026 Financial Results
- SEC Form CERT filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form FWP filed by British American Tobacco Industries p.l.c.
Latest OBIO
- Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,076 shares, decreasing direct ownership by 0.52% to 589,989 units (SEC Form 4) to cover taxes
- Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 203 shares, decreasing direct ownership by 1% to 18,441 units (SEC Form 4) to satisfy withholding tax
- Officer Sherman Darren bought $10,660 worth of shares (2,000 units at $5.33) and covered exercise/tax liability with 4,925 shares, decreasing direct ownership by 0.43% to 1,149,402 units (SEC Form 4) to satisfy tax liability
- Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
- Director Mack John Prosper covered exercise/tax liability with 4,885 shares, decreasing direct ownership by 7% to 66,544 units (SEC Form 4) (tax liability)
- Director Fain Eric S covered exercise/tax liability with 5,145 shares (SEC Form 4) (withholding obligation)
- Director Pacitti David covered exercise/tax liability with 3,761 shares, decreasing direct ownership by 6% to 54,750 units (SEC Form 4) to satisfy withholding tax
- Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
- SEC Form 10-Q filed by Orchestra BioMed Holdings Inc.